Yiran Gan 4/8/25 Yiran Gan 4/8/25 Vascular risk factors and astrocytic marker for the glymphatic system activity Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial Read More Yiran Gan 4/8/25 Yiran Gan 4/8/25 Increased Levels of Plasma Alzheimer’s Disease Biomarkers and Their Associations with Brain Structural Changes and Carotid Intima-Media Thickness in Cognitively Normal Obstructive Sleep Apnea Patients Read More Newer Posts Older Posts
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Vascular risk factors and astrocytic marker for the glymphatic system activity Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD Drosophila Model Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Comparing the effects of olfactory-based sensory stimulation and board game training on cognition, emotion, and blood biomarkers among individuals with dementia: A pilot randomized controlled trial Read More
Yiran Gan 4/8/25 Yiran Gan 4/8/25 Increased Levels of Plasma Alzheimer’s Disease Biomarkers and Their Associations with Brain Structural Changes and Carotid Intima-Media Thickness in Cognitively Normal Obstructive Sleep Apnea Patients Read More
